Research Article

Association of Biomarker Level with Cardiovascular Events: Results of a 4-Year Follow-Up Study

Table 2

Level of biochemical parameters in groups with and without event.

VariablesTotal N = 223No outcome N = 188 (84.3%)Composite end point N = 35 (15.7%)MACE n = 15χ2 levelχ2 level

Cholesterol, mmol/L, median (Q25–Q75)5.3 (4.57–6.3)5.56 (4.68–6.33)5.66 (4.50–6.59)5.53 (4.37–7.08)0.590.560.090.93
Glucose, mmol/L, median (Q25–Q75)5.4 (5.1–5.8)5.85 (5.10–5.80)6.32 (5.10–6.1)6.92 (5.20–6.30)1.560.210.880.34
Endocan, pg/ml, median (Q25–Q75)733.2 (68.8–3432.8)718.6 (101.8–3432.8)957.0 (68.8–2150.9)1185.6 (355.1–2150.9)2.390.0173.27≤0.001
CXCL16, pg/ml, median (Q25–Q75)324.8 (4–2673.0)310.0 (4–1685)432.3 (64–2673.0)774.2 (293.0–2673.0)2.620.0093.45≤0.001
H-FABP, pg/ml, median (Q25–Q75)2346.8 (343.2–53447.7)2154.2 (422.4–53447.7)3245.6 (343.2–23509.9)5443.4 (1837.4–23509.9)2.870.0043.100.002

χ2 and between the no-outcome group and outcome group with a composite endpoint; χ2 and between the no-outcome group and outcome group with a MACE.